Skip NavigationSkip to Content

Inhibitors of the NF-kappaB activation pathway from Cryptocarya rugulosa

  1. Author:
    Meragelman, T. L.
    Scudiero, D. A.
    Davis, R. E.
    Staudt, L. M.
    McCloud, T. G.
    Cardellina, J. H. 2nd.
    Shoemaker, R. H.
  2. Author Address

    Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, Maryland, USA.
    1. Year: 2009
    2. Date: Mar 27
    3. Epub Date: 12/20/2008
  1. Journal: Journal of Natural Products
    1. 72
    2. 3
    3. Pages: 336-9
  2. Type of Article: Article
  3. ISSN: 1520-6025 (Electronic);0163-3864 (Linking)
  1. Abstract:

    The nuclear factor-kappaB (NF-kappaB) signaling pathway is constitutively active in many types of cancers and is a potential therapeutic target. Using a cell-based assay for stability of inhibitor of kappa B (IkappaB), a critical regulator of NF-kappaB activity, we found that an organic solvent extract of the plant Cryptocarya rugulosa inhibited constitutive NF-kappaB activity in human lymphoma cell lines. The active components were identified as rugulactone, a new alpha-pyrone (1), and the known cryptocaryone (2). Rugulactone was the more active compound, exhibiting up to 5-fold induction of IkappaB at 25 microg/mL; maximal activity was observed with 10 h exposure of test cells to 1 or 2.

    See More

External Sources

  1. DOI: 10.1021/np800350x
  2. PMID: 19093800

Library Notes

  1. Fiscal Year: FY2008-2009
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel